Stocktoria

ECOLAB INC. ECL

ECOLAB INC. (ECL) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.94% (safety: safe). FY2025 revenue was $16.1B at a 12.9% net margin.

Chart by TradingView
62/100
Stocktoria Quality Score · grade B
4/9
Piotroski F — financial health
3.24
Altman Z″ — distress risk · safe
1.1%
Dividend yield 5y avg · safe · Dividend payout 36.3%
-2.51
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 2 2 3 4 4 5 6 5 4 2016201720182019202020212022202320242025
Altman Z″
3.02 2.99 3.05 3.29 3.34 2.76 2.83 3.12 3.56 3.24 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$278.43 as of 2026-08-01 · +0.5% 1y
$256.00$308.3552-wk

Beneish M-score: -2.51 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$79.8B
P / E38.5×
Dividend yield 5y avg1.1%
Net margin 5y avg10.4%
Return on equity 5y avg18.6%
Beta0.89
Employees48,000

Analyst price target

$324.67 +16.6% vs last
consensus: buy · 21 analysts
target range $295.00 – $360.00 · median $330.00
5 strong buy · 15 buy · 6 hold
Recent analyst actions
DateFirmRating
2026-07-30Wells FargoEqual-Weight (main)
2026-07-29MizuhoOutperform (main)
2026-07-29BMO CapitalOutperform (main)
2026-07-29JP MorganOverweight (main)
2026-07-17OppenheimerOutperform (up)
2026-07-09Deutsche BankBuy (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$9.43
Forward P / E29.5×
Next ex-dividend2026-09-15

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$611,579 on the open market · 4 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 45%
Net marginstronger than 84%
Return on equitystronger than 90%
Revenue growthstronger than 41%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.017
Retained earnings / assets0.52
EBIT / assets0.111
Equity / liabilities0.658

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
ECLECOLAB INC.4/93.2438.5+2.2%
CHDCHURCH & DWIGHT CO INC /DE/7/94.2232+1.6%
SCLSTEPAN CO7/93.7127+7%
WNWMeiwu Technology Co Ltd4/9
BYAHPark Ha Biological Technology Co., Ltd.5/9
PGPROCTER & GAMBLE Co6/94.6721.6+3.3%
VFSVinFast Auto Ltd.4/9-13.01+57.9%

All Manufacturing companies →

About ECOLAB INC.

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

FAQ

Is ECL financially healthy?

ECOLAB INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does ECL pay a dividend, and is it safe?

Yes. ECOLAB INC. pays a dividend yielding about 0.94% with a 36.3% payout ratio, rated “safe” for safety.

How profitable is ECL?

In FY2025, ECOLAB INC. had a net margin of 12.9% and a return on equity of 21.2%.

Is ECL overvalued or undervalued?

ECOLAB INC. trades at about 38.2× trailing earnings — near its 10-year norm (10-year range 26.9×–48.5×, median 36.8×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for ECL?

The average Wall-Street price target for ECOLAB INC. is $324.67, about 16.6% above the recent price, from 21 analysts (consensus: buy).

Is ECL a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on ECOLAB INC.: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 38.5×, a dividend yield of 0.94%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.